Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Solid Tumor × fedratinib × 90 days × Clear all

Sponsor

Conditions

Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1

Interventions

Injections 3 zimberelimab 1 tumor-cells apoptosis factor, human 1 toripalimab 1 tislelizumab 1 tazemetostat 1 pembrolizumab 1 cemiplimab 1 cedazuridine 1 WW Domain-Containing Oxidoreductase 1 Specimen Handling 1 RE1-silencing transcription factor 1 Proton Therapy 1 Nivolumab 1 Ipilimumab 1 Indocyanine Green 1 Fluorodeoxyglucose F18 1 Doxorubicin 1 Decitabine 1 Cisplatin 1 Cetuximab 1 Carboplatin 1 Blood Specimen Collection 1 Blood Component Removal 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡